Ocrevus (ocrelizumab)

pCPA File Number: 21033
Negotiation Status:
Concluded with an LOI
Indication(s):
Primary Progressive Multiple Sclerosis
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
SR0542-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: